Article

RPB awards $4.8M in grants to supporteye research

New York-Research to Prevent Blindness (RPB), announced 44 new grants totaling $4.8 million for investigations into the causes, treatment, and prevention of all blinding diseases.

New York-Research to Prevent Blindness (RPB), announced 44 new grants totaling $4.8 million for investigations into the causes, treatment, and prevention of all blinding diseases.

In the past 18 months, RPB has committed more than $12.9 million to eye research.

Across the United States, RPB-supported laboratories are investigating the entire spectrum of eye disease: from cataract, glaucoma, and diabetic reti-nopathy to age-related macular degeneration, retinitis pigmentosa, and eye movement disorders.

The latest awards were given to 29 medical institutions, including unrestricted and challenge grants to depart-ments of ophthalmology at 22 medical schools and 22 awards to individual scientists.

The recently-approved grant projects include:

Among RPB's vision scientists fighting eye diseases are nine active Jules and Doris Stein RPB Professors who receive $375,000 each over 5 years and up to $100,000 in a matching grant for laboratory construction.

An additional $150,000 may be awarded during a 2-year extension of the award.

RPB currently supports eye research at 54 medical institutions throughout the United States.

For a complete listing of grant recipients, go to http://www.rpbusa.org. OT

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.